We are live on
!
Find out more
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
JP Morgan Chase
New York
| $10K | +$9.94K | +500 | New |
|
52
Creative Planning
Overland Park,
Kansas
| $3K | -$2.98K | -150 | -47% |
|
|
NFG
53
Next Financial Group
Houston,
Texas
| $3K | +$2.98K | +150 | New |
|
|
KTC
54
Kistler-Tiffany Companies
Berwyn,
Pennsylvania
| $2K | +$1.99K | +100 | New |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| $2K | +$1.99K | +100 | New |
|
|
PA
56
Parallel Advisors
San Francisco,
California
| $2K | +$2.38K | +120 | New |
|
|
WEC
57
Winslow Evans & Crocker
Boston,
Massachusetts
| $1.01K | +$994 | +50 | New |
|
|
WVP
58
Worth Venture Partners
Fort Lee,
New Jersey
| $1K | +$795 | +40 | New |
|
59
BNP Paribas Financial Markets
Paris,
France
| $20 | – | – | – |
|
|
VKH
60
Virtu KCG Holdings
New York
| – | -$218K | -13,986 | Closed |
|
|
CG
61
Cutler Group
San Francisco,
California
| – | -$3.97K | -200 | Closed |
|
62
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1.95K | -98 | -98% |
|